Developer docs
API playgroundTry for free, no card

Search company profiles

Yokohama Capital

Full company profile

uuid000ba62

Namestring
Yokohama Capital
Legal namestring
横浜キャピタル株式会社 (Yokohama Capital Co., Ltd.)
Company typeenum
Private
Founded yearint
1984
Descriptiontext

Yokohama Capital Co., Ltd. (横浜キャピタル株式会社) is a Japan-based venture capital and private equity firm founded in March 1984 as a wholly-owned subsidiary of Yokohama Bank (Bank of Yokohama), now operating under Yokohama Financial Group. The firm provides equity investment and management support across three core strategies: venture and growth-stage investment for startups, business succession and buyout investment for small and medium-sized enterprises, and business regeneration (turnaround) investment for companies requiring restructuring. Its primary catchment is Kanagawa Prefecture and the Tokyo metropolitan area, supplemented by a cross-regional partnership with Chiba Bank covering Chiba Prefecture.

The firm operates a multi-vehicle fund platform totaling roughly ¥210B in disclosed AUM, anchored by Yokohama Growth1号 (¥30B, venture/growth, established September 2024), Yokohama Next (¥60B, versatile VC and succession, March 2023), Yokohama Next2号 (¥50B, buyout/succession/regeneration, September 2024), the Chiba-Yokohama Partnership 1号 Fund (March 2021), and the Kanagawa SME Support Fund (¥20B, January 2019), plus legacy vehicles including Mirai Regional Activation and Kanagawa Tourism Activation. LPs include Yokohama Bank, Hamgin Finance, Hamgin Sogo Research Institute, Chiba Bank, the Development Bank of Japan, and the Organization for Small & Medium Enterprises. Co-investment with regional financial institutions and policy-aligned agencies is a structural feature rather than an exception.

Portfolio construction spans seed-to-Series A opportunities across biotech/pharma (Reborna Biosciences, Eurus Therapeutics, PURMX Therapeutics, Lekmed), clean energy/GX (PXP perovskite-chalcopyrite tandem solar, EV Motors Japan), space tech (Pale Blue water-propellant ion thrusters, Iwaya Giken high-altitude balloons), AI/data services (NABLA Mobility for aviation decarbonization, any Inc./Qast knowledge management, GVA TECH legal AI), Web3 (JPYC yen stablecoin), IoT (Nature Remo), cultivated meat (Integriculture), and agricultural robotics (Regmin). Revenue mechanics consist of traditional VC management fees on committed/invested capital across active funds and capital appreciation/realized carry from exits. The firm references an IPO track record of more than 100 companies between 1988 and 2024 across TSE (First Section, Growth/Mothers) and JASDAQ venues. Distribution relies almost exclusively on parent-bank channel — Yokohama Bank's Kanagawa/Tokyo branch network drives deal origination, post-investment business matching, and limited-partner support; the firm operates from a single headquarters in Minato Mirai, Yokohama, and joined the Japan Venture Capital Association in June 2023.

Short descriptiontext

Yokohama Capital is a Yokohama-headquartered venture capital and private equity firm, wholly owned by Yokohama Bank (Yokohama Financial Group), providing equity investment, business succession/buyout financing, and turnaround support for startups and SMEs across Kanagawa and Tokyo.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersYokohama, Japan
HQ citystring
Yokohama
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investment, business succession support, SME growth capital, buyout investment, business regeneration
Industry2 codes
1FSANABAA
CodeFSANABAAPrimaryYes
2BPAHAOAE
CodeBPAHAOAEPrimaryNo
NAICS code3 codes
  • 5259
  • 5239
  • 52399
SIC code1 code
  • 6799
Product category
Venture Capital
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Fund Management Fees
TypeManaged Services
Description

Yokohama Capital earns management fees from operating investment funds. The firm manages multiple funds with total AUM of 210 billion yen across active funds including Yokohama Growth1号 (30 billion yen), Yokohama Next2号 (50 billion yen), and Yokohama Next (60 billion yen).

yokohama-capital.co.jp
2Investment Returns / Capital Gains
TypeLicensing Royalties
Description

The firm generates returns through equity investments in portfolio companies, benefiting from IPO exits and capital appreciation. Historical IPO track record includes over 100 companies that have gone public.

yokohama-capital.co.jp
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Yokohama Capital provides equity investment and post-investment management support to startups, growth-stage companies, and SMEs through multiple dedicated investment funds. Core activities span three categories: venture/growth investment supporting startup expansion, business succession and buyout investment enabling ownership transition, and business regeneration investment supporting corporate turnaround scenarios. Total assets under management amount to 210 billion yen across active funds, with a historical track record of over 100 portfolio company IPOs since 1988.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 100 IPO successes spanning 1988-2024
+2 more records
Product overview1 text field

Yokohama Capital (横浜キャピタル株式会社) is a venture capital and private equity firm established in 1984 as a subsidiary of Yokohama Bank (now part of Yokohama Financial Group). The company operates a diversified portfolio of investment funds including venture capital funds (Yokohama Growth1号, Yokohama Next), buyout/succession funds (Yokohama Next2号), and regional partnership funds. Their investment focus areas span startups, growth companies, and companies requiring business succession support across Kanagawa Prefecture and Tokyo. The portfolio includes knowledge management platforms (Qast), aviation optimization AI solutions (NABLA Mobility), renewable energy technology (PXP solar cells), and biotech/pharmaceutical ventures (Reborna Biosciences, Eurus Therapeutics, PURMX Therapeutics, Recmed, Varinos).

Product and service5 records
1Yokohama Growth 1号 Fund (横浜キャピタル Growth 1号投資事業有限責任組合)
CategoryVenture/Growth Investment Fund
Description

A venture capital and growth support fund targeting startups and growth-stage companies seeking equity capital in Kanagawa Prefecture and surrounding areas. Fund size 3 billion yen; 10-year investment period.

2Yokohama Next 2号 Fund (Yokohama Next 2号投資事業有限責任組合)
CategoryBuyout/Succession Investment Fund
Description

A buyout, business succession, and business revitalization fund providing equity capital for SMEs requiring ownership transition or turnaround support. Fund size 5 billion yen.

3Yokohama Next Fund (Yokohama Next投資事業有限責任組合)
CategoryVenture/Succession Investment Fund
Description

A versatile investment fund supporting venture capital, growth equity, and interim ownership arrangements for business succession or transfer purposes. Fund size 6 billion yen.

4Chiba-Yokohama Partnership 1号 Fund (千葉・横浜パートナーシップ1号投資事業有限責任組合)
CategoryRegional Partnership Investment Fund
Description

A regional partnership fund co-established with Chiba Bank targeting business succession and growth investment opportunities for SME customers of both banks across Kanagawa and Chiba prefectures.

5Kanagawa SME Support Fund (かながわ中小企業支援ファンド投資事業有限責任組合)
CategorySME Support Fund
Description

A 2 billion yen fund providing medium-to-long-term equity participation support to SMEs in Kanagawa Prefecture, in collaboration with regional financial institutions and the SME Agency.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

VC subsidiary of Mizuho Financial Group. Directly comparable bank-affiliated VC with multi-fund strategy across venture, growth, and succession investments in Japan.

TypeDirect peer
Description

Investment arm of Chiba Bank, which is itself an LP partner of Yokohama Capital in the Chiba-Yokohama Partnership Fund. Comparable as a regional bank-affiliated VC operating in adjacent Japanese geography.

TypeBroad incumbent
Description

One of Japan's largest VC/PE managers, operating numerous venture, growth, and buyout funds with a national footprint. Comparable in strategy but materially larger in AUM and brand recognition.

TypeBroad incumbent
Description

Japan's largest venture capital and buyout firm with >¥500B AUM. Directly comparable as it operates VC, growth, and buyout/succession funds across Japan; far larger scale but same multi-strategy VC/PE model.

TypeEmerging player
Description

Independent VC firm affiliated with the Globis group, focused on Japanese growth-stage startups. Comparable as a Japanese VC investor but operates independently rather than as a bank subsidiary.

TypeDirect peer
Description

VC arm of the Development Bank of Japan. Notably DBJ is already an LP partner of Yokohama Capital in the Tsunagu Business Succession Fund, making this a co-LP and direct operational peer.

TypeDirect peer
Description

Investment arm of Daiwa Securities Group, providing equity capital to Japanese startups and SMEs including succession/MBO deals. Comparable as a financial-group-affiliated VC/PE firm with diversified strategy.

TypeDirect peer
Description

Wholly-owned VC subsidiary of Nippon Life Insurance, providing equity capital and management support to Japanese startups and growth companies. Closest structural analogue — a large insurance/financial group's VC arm — making it a directly comparable bank/insurer-affiliated VC.

TypeDirect peer
Description

VC arm of Mitsubishi UFJ Financial Group, one of Japan's mega-banks. Comparable bank-affiliated VC operating multiple funds targeting venture and growth-stage Japanese companies.

TypeDirect peer
Description

VC arm of Sumitomo Mitsui Banking Corporation. Comparable as a bank-affiliated VC with national deal flow and multi-fund operations targeting startups and growth-stage companies.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment54 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Yokohama Capital

Venture Capitalyokohama-capital.co.jp

Yokohama Capital is a Yokohama-headquartered venture capital and private equity firm, wholly owned by Yokohama Bank (Yokohama Financial Group), providing equity investment, business succession/buyout financing, and turnaround support for startups and SMEs across Kanagawa and Tokyo.

What Yokohama Capital does

Yokohama Capital Co., Ltd. (横浜キャピタル株式会社) is a Japan-based venture capital and private equity firm founded in March 1984 as a wholly-owned subsidiary of Yokohama Bank (Bank of Yokohama), now operating under Yokohama Financial Group. The firm provides equity investment and management support across three core strategies: venture and growth-stage investment for startups, business succession and buyout investment for small and medium-sized enterprises, and business regeneration (turnaround) investment for companies requiring restructuring. Its primary catchment is Kanagawa Prefecture and the Tokyo metropolitan area, supplemented by a cross-regional partnership with Chiba Bank covering Chiba Prefecture.

The firm operates a multi-vehicle fund platform totaling roughly ¥210B in disclosed AUM, anchored by Yokohama Growth1号 (¥30B, venture/growth, established September 2024), Yokohama Next (¥60B, versatile VC and succession, March 2023), Yokohama Next2号 (¥50B, buyout/succession/regeneration, September 2024), the Chiba-Yokohama Partnership 1号 Fund (March 2021), and the Kanagawa SME Support Fund (¥20B, January 2019), plus legacy vehicles including Mirai Regional Activation and Kanagawa Tourism Activation. LPs include Yokohama Bank, Hamgin Finance, Hamgin Sogo Research Institute, Chiba Bank, the Development Bank of Japan, and the Organization for Small & Medium Enterprises. Co-investment with regional financial institutions and policy-aligned agencies is a structural feature rather than an exception.

Portfolio construction spans seed-to-Series A opportunities across biotech/pharma (Reborna Biosciences, Eurus Therapeutics, PURMX Therapeutics, Lekmed), clean energy/GX (PXP perovskite-chalcopyrite tandem solar, EV Motors Japan), space tech (Pale Blue water-propellant ion thrusters, Iwaya Giken high-altitude balloons), AI/data services (NABLA Mobility for aviation decarbonization, any Inc./Qast knowledge management, GVA TECH legal AI), Web3 (JPYC yen stablecoin), IoT (Nature Remo), cultivated meat (Integriculture), and agricultural robotics (Regmin). Revenue mechanics consist of traditional VC management fees on committed/invested capital across active funds and capital appreciation/realized carry from exits. The firm references an IPO track record of more than 100 companies between 1988 and 2024 across TSE (First Section, Growth/Mothers) and JASDAQ venues. Distribution relies almost exclusively on parent-bank channel — Yokohama Bank's Kanagawa/Tokyo branch network drives deal origination, post-investment business matching, and limited-partner support; the firm operates from a single headquarters in Minato Mirai, Yokohama, and joined the Japan Venture Capital Association in June 2023.

Yokohama Capital firmographics

Firmographics
Name
Yokohama Capital
Legal name
横浜キャピタル株式会社 (Yokohama Capital Co., Ltd.)
Website
https://yokohama-capital.co.jp/
Company type
Private
Founded year
1984
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Yokohama Capital is a Yokohama-headquartered venture capital and private equity firm, wholly owned by Yokohama Bank (Yokohama Financial Group), providing equity investment, business succession/buyout financing, and turnaround support for startups and SMEs across Kanagawa and Tokyo.
Ownership category
akta.pro rank

Where Yokohama Capital is headquartered

Location

Headquarters

HQ city
Yokohama
HQ country
Japan
HQ region
Asia

Offices1 record

Markets served

Yokohama Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Fund Management Fees: Yokohama Capital earns management fees from operating investment funds. The firm manages multiple funds with total AUM of 210 billion yen across active funds including Yokohama Growth1号 (30 billion yen), Yokohama Next2号 (50 billion yen), and Yokohama Next (60 billion yen).
  2. Investment Returns / Capital Gains: The firm generates returns through equity investments in portfolio companies, benefiting from IPO exits and capital appreciation. Historical IPO track record includes over 100 companies that have gone public.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Yokohama Capital product offering

Product offering

Core offering

Yokohama Capital provides equity investment and post-investment management support to startups, growth-stage companies, and SMEs through multiple dedicated investment funds. Core activities span three categories: venture/growth investment supporting startup expansion, business succession and buyout investment enabling ownership transition, and business regeneration investment supporting corporate turnaround scenarios. Total assets under management amount to 210 billion yen across active funds, with a historical track record of over 100 portfolio company IPOs since 1988.

Product overview

Yokohama Capital (横浜キャピタル株式会社) is a venture capital and private equity firm established in 1984 as a subsidiary of Yokohama Bank (now part of Yokohama Financial Group). The company operates a diversified portfolio of investment funds including venture capital funds (Yokohama Growth1号, Yokohama Next), buyout/succession funds (Yokohama Next2号), and regional partnership funds. Their investment focus areas span startups, growth companies, and companies requiring business succession support across Kanagawa Prefecture and Tokyo. The portfolio includes knowledge management platforms (Qast), aviation optimization AI solutions (NABLA Mobility), renewable energy technology (PXP solar cells), and biotech/pharmaceutical ventures (Reborna Biosciences, Eurus Therapeutics, PURMX Therapeutics, Recmed, Varinos).

Differentiator

Problem solved

Functional benefit

Products and services

  • Yokohama Growth 1号 Fund (横浜キャピタル Growth 1号投資事業有限責任組合) A venture capital and growth support fund targeting startups and growth-stage companies seeking equity capital in Kanagawa Prefecture and surrounding areas. Fund size 3 billion yen; 10-year investment period.
  • Yokohama Next 2号 Fund (Yokohama Next 2号投資事業有限責任組合) A buyout, business succession, and business revitalization fund providing equity capital for SMEs requiring ownership transition or turnaround support. Fund size 5 billion yen.
  • Yokohama Next Fund (Yokohama Next投資事業有限責任組合) A versatile investment fund supporting venture capital, growth equity, and interim ownership arrangements for business succession or transfer purposes. Fund size 6 billion yen.
  • Chiba-Yokohama Partnership 1号 Fund (千葉・横浜パートナーシップ1号投資事業有限責任組合) A regional partnership fund co-established with Chiba Bank targeting business succession and growth investment opportunities for SME customers of both banks across Kanagawa and Chiba prefectures.
  • Kanagawa SME Support Fund (かながわ中小企業支援ファンド投資事業有限責任組合) A 2 billion yen fund providing medium-to-long-term equity participation support to SMEs in Kanagawa Prefecture, in collaboration with regional financial institutions and the SME Agency.

Quantifiable outcome

  • Over 100 IPO successes spanning 1988-2024
  • +2 more outcomes

Companies that use Yokohama Capital

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Yokohama Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Yokohama Capital partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights7 records

Yokohama Capital competitors and assessment

Company assessment

Direct peers

  • Mizuho Capital: VC subsidiary of Mizuho Financial Group. Directly comparable bank-affiliated VC with multi-fund strategy across venture, growth, and succession investments in Japan.
  • Chiba Capital: Investment arm of Chiba Bank, which is itself an LP partner of Yokohama Capital in the Chiba-Yokohama Partnership Fund. Comparable as a regional bank-affiliated VC operating in adjacent Japanese geography.
  • DBJ Capital: VC arm of the Development Bank of Japan. Notably DBJ is already an LP partner of Yokohama Capital in the Tsunagu Business Succession Fund, making this a co-LP and direct operational peer.
  • Daiwa Corporate Investment: Investment arm of Daiwa Securities Group, providing equity capital to Japanese startups and SMEs including succession/MBO deals. Comparable as a financial-group-affiliated VC/PE firm with diversified strategy.
  • Nissay Capital: Wholly-owned VC subsidiary of Nippon Life Insurance, providing equity capital and management support to Japanese startups and growth companies. Closest structural analogue — a large insurance/financial group's VC arm — making it a directly comparable bank/insurer-affiliated VC.
  • Mitsubishi UFJ Capital: VC arm of Mitsubishi UFJ Financial Group, one of Japan's mega-banks. Comparable bank-affiliated VC operating multiple funds targeting venture and growth-stage Japanese companies.
  • SMBC Venture Capital: VC arm of Sumitomo Mitsui Banking Corporation. Comparable as a bank-affiliated VC with national deal flow and multi-fund operations targeting startups and growth-stage companies.

Broad incumbents

  • SBI Investment: One of Japan's largest VC/PE managers, operating numerous venture, growth, and buyout funds with a national footprint. Comparable in strategy but materially larger in AUM and brand recognition.
  • JAFCO Group: Japan's largest venture capital and buyout firm with >¥500B AUM. Directly comparable as it operates VC, growth, and buyout/succession funds across Japan; far larger scale but same multi-strategy VC/PE model.

Emerging players

  • Globis Capital Partners: Independent VC firm affiliated with the Globis group, focused on Japanese growth-stage startups. Comparable as a Japanese VC investor but operates independently rather than as a bank subsidiary.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Yokohama Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Yokohama Capital leadership team

Management profile

Number of profiles

Profiles2 records

Yokohama Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Yokohama Capital M&A and investment

M&A and investment

M&A

Investments54 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Yokohama Capital

What does Yokohama Capital do?

Yokohama Capital provides equity investment and post-investment management support to startups, growth-stage companies, and SMEs through multiple dedicated investment funds. Core activities span three categories: venture/growth investment supporting startup expansion, business succession and buyout investment enabling ownership transition, and business regeneration investment supporting corporate turnaround scenarios. Total assets under management amount to 210 billion yen across active funds, with a historical track record of over 100 portfolio company IPOs since 1988.

Is Yokohama Capital a public or private company?

Yokohama Capital is a private company. It is classified as corporate owned and is currently operating.

When was Yokohama Capital founded?

Yokohama Capital was founded in 1984. It employs 1,001 to 5,000 people.

Where is Yokohama Capital based?

Yokohama Capital is headquartered in Yokohama, Japan, in the Asia region.

How does Yokohama Capital make money?

Two revenue lines are on record. Fund Management Fees are the primary driver. The others are investment Returns / Capital Gains.

Who are Yokohama Capital's main competitors?

Direct peers on record are Mizuho Capital, Chiba Capital, DBJ Capital, Daiwa Corporate Investment, Nissay Capital, Mitsubishi UFJ Capital and SMBC Venture Capital. Broad incumbents are SBI Investment and JAFCO Group. Globis Capital Partners is listed as an emerging player.

Does Yokohama Capital have an API?

No public API is recorded for Yokohama Capital.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Thebridge9lione, a Pharmaceutical Distribution DX Company, Raises ¥120 Million in Series A Led by Yokohama Capital9lione raised ¥120 million in a Series A round led by Yokohama Capital, bringing total funding to ¥440 million. The company supplies surplus pharmaceuticals and operates a cloud-based management system, with annual distribution exceeding ¥2 billion. Funds will expand logistics, develop AI-driven products, and strengthen recruitment.Venture-Pitch-OnlinePharmaceutical Distribution DX Startup 9lione Raises 120 Million Yen in Series A, Bringing Total Funding to 440 Million Yen9lione Inc. raised 120 million yen in a Series A round led by Yokohama Capital, bringing total funding to 440 million yen. The platform redistributes surplus pharmaceutical inventory from medical institutions to facilities in need. Funds will expand operational bases and develop AI-powered inventory visualization and automated trading features.Prtimes医療ベンチャーVarinos、シリーズD総額約12.5億円の資金調達を完了Varinos raised about 1.25 billion yen in a Series D round led by Mirai Sozo Investments, with new investors Mitsui Chemicals and Yokohama Capital. The funds will support test quality improvements, overseas expansion, and new business development, including a research contract with Mitsui Chemicals.ThebridgeVarinos Secures Approximately ¥1.25 Billion in Series D Funding for Uterine Flora TestingVarinos raised approximately ¥1.25 billion in Series D funding led by Mirai Creation Investments, with Mitsui Chemicals and Yokohama Capital participating. The company's uterine flora testing service has been introduced in over 400 medical institutions, with cumulative samples exceeding 50,000. Funds will support improving testing quality, expanding domestic and overseas medical institutions, and developing new businesses.Evm-JWe have raised 195 million yen through a third-party allotment of shares.EV Motors Japan Co., Ltd. raised 195 million yen in a Series D funding round from Yokohama Capital Co., Ltd. and Zhongchi Intelligence and Technology (Yangzhou) Co., Ltd. by June 28, 2024. This brings the company's total cumulative funding to approximately 6.56 billion yen.Prtimesテープス株式会社、New Commerce Ventures・横浜キャピタル・横浜銀行より資金調達を実施し、EC 特化ノーコードツール「TēPs」の事業開発体制を強化Teps Inc. has raised 130 million yen through a third-party share allocation and loans from Yokohama Bank, involving New Commerce Ventures Inc. and Yokohama Capital Co., Ltd. as underwriters. The funding is aimed at enhancing the development of TēPs, a no-code tool designed to automate various processes for e-commerce operators, simplifying their operations. The company intends to expand its functionalities and improve usability by adding new partners and support systems in the future.PurmxPURMX Therapeutics Raised Funds through a Third-party Allotment of New Shares from Yokohama CapitalPURMX Therapeutics, Inc. has raised capital through a third-party allotment of new shares to Yokohama Next Investment Limited Liability Partnership. This funding aims to bolster the company's financial position. The allotment reflects ongoing efforts by PURMX Therapeutics to secure investment for its operations.PrtimesIwatani Giken has raised 570 million yen through a third-party allocation of shares, bringing the total amount raised to approximately 1.6 billion yen.Iwaya Giken, a space development company based in Sapporo, raised an additional 570 million yen through a third-party share allocation by October 10, 2023. This funding round brings the company's total capital raised since its seed round in August 2020 to approximately 1.6 billion yen. The investment was underwritten by Incubate Fund, Yokohama Capital, and Toyota Boshoku.